News

Wells Fargo raises price target on Synopsys stock to $475. Here’s what made analyst Joe Quatrochi upgrade SNPS shares today.

Morgan Stanley upgrades Synopsys stock to "Overweight." Here’s why analyst Lee Simpson sees significant upside in SNPS shares from current levels.

The chip design giant is pushing into a new, more lucrative business model, and while its stock has a strong record of bouncing back, there's a catch you can't ignore.

Investing.com -- Morgan Stanley has taken a more selective stance on European semiconductor stocks, staying positive on the sector overall while adjusting ratings and price targets as the memory cycle nears a turn and valuations diverge.

Investing.com -- Morgan Stanley has upgraded Synopsys to Overweight and turned more selective on European semiconductor stocks, citing widening valuation dispersion and signs that the memory cycle is nearing a late-cycle turn.

Wall Street returns from summer vacation to a market suddenly bracing for a rate hike, with fresh analyst calls on Intel, Lockheed Martin, Amgen, and SpaceX adding more pressure points to an already tense week.

Synopsys is facing restructuring pressure, but resilient results and AI-driven demand could keep its investment prospects solid.

Both software players are riding the AI wave, but PTC offers a clearer forward path with stronger growth and profitability, while Oracle asks investors to fund a massive, costly buildout.

The design software giant is betting on a new strategy, and its stock history offers a strong blueprint for buying on weakness.

Synopsys powers nearly every advanced chip on the planet, yet its stock has cratered while the broader market surged, and Wall Street analysts are betting that gap closes in a hurry.

Synopsys (SNPS) booked revenue of $2.477 billion in fiscal Q3 2026, up about 42% year over year, and the shares have still lost about 30% over the past twelve months. Look past that headline at the line underneath it: EDA grew 8.5%. That single-digit number is the pace of the design tools business Synopsys had before the Ansys deal.

Though Synopsys has lagged behind the broader Nasdaq Composite over the past year, Wall Street analysts remain strongly optimistic about the stock’s prospects.

Marvell and Synopsys both profit from the AI chip boom, but one company is quietly handing hyperscalers the tools to cut the other out entirely. The tension between them reveals something uncomfortable about where custom silicon money actually flows.

Synopsys stock presents a clear valuation split for investors. The intrinsic value estimate from a Discounted Cash Flow (DCF) approach points to a discount to current trading levels, while market based multiples and a low overall value score suggest the shares are not obviously cheap. Over the past 1 year the share price has fallen 29.9%, which means investors are assessing Synopsys after a meaningful reset rather than at a recent peak. Stronger demand for Synopsys tools linked to AI and...

Imagine two very different futures for your Autodesk (ADSK) stock a year from now. In one, it’s trading near $165. In the other, it’s pushing past $402.44. The options market isn’t picking a winner; it’s telling you that both are plausible destinations. For a shareholder, that’s not a theoretical exercise. It’s the risk you already own.

AI's memory crunch could extend through 2027, driving chipmakers while pressuring electronics firms. Which ETFs could emerge as winners?

Jensen Huang turned a modest chip startup into the backbone of the global AI arms race, and his personal fortune now rivals the biggest names in tech. But three mounting challenges could test whether Nvidia's reign at the top is as unshakeable as it appears.

Ceva has fallen nearly 19% in a month despite Q2 beats and solid growth, but its premium valuation suggests investors may want to wait before buying.

Synopsys just posted explosive revenue growth that dwarfs its closest EDA rival, yet the market prices it at a fraction of that rival's multiple. Something in that gap tells a story most investors are missing.

The mean of analysts' price targets for Synopsys (SNPS) points to a 25.4% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

According to the average brokerage recommendation (ABR), one should invest in Synopsys (SNPS). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?

Why investing for the long run, especially if you buy certain popular stocks, could reap huge rewards.

The chip-design software maker wants to add a royalty on the custom AI chips its biggest customers build, on top of the interface IP license fees it already charges them.

Revenue hit $2.477 billion with 42% growth as Ansys integration accelerated.

Synopsys, Inc. (NASDAQ:SNPS) delivered a stronger-than-expected fiscal third quarter, but its results present two different views of profitability. Revenue rose 42% year over year to $2.477 billion, ahead of consensus estimates of $2.44 billion. Company-defined non-GAAP earnings reached $3.91 per diluted share, above consensus estimates of $3.67, while GAAP earnings were $2.84 per share. The […]

Opening Bid Host Brooke DiPalma is joined by the panel of Prime Capital Financial chief investment officer Will McGough, Slatestone Wealth chief market strategist Kenny Polcari, and F.L. Putnam Investment Management co-chief market strategist & portfolio manager Ellen Hazen to weigh whether now is the time to buy into software stocks.

PDF Solutions outpaces Synopsys with stronger revenue growth, improving margins, major customer wins and a 20% growth target.

Synopsys (SNPS) is back in focus after its third quarter fiscal 2026 report on 26 August, which showed stronger than expected revenue and earnings, as well as a raised full year outlook supported by AI driven demand. The Q3 surprise and higher guidance triggered a sharp short term rebound in Synopsys, with a 1 day share price return of 13.39% and a 30 day share price return of 21.12%. However, the total shareholder return over one year is still down 24.06%, so recent momentum is picking up...

Synopsys, Inc. recently reported past third-quarter fiscal 2026 results, with revenue rising to US$2.48 billion and GAAP diluted EPS from continuing operations reaching US$2.84, alongside a year-on-year increase in quarterly net income to US$545.8 million. Despite this strong quarter, net income for the first nine months of fiscal 2026 was US$627.86 million versus US$883.52 million a year earlier, highlighting how integration costs, portfolio shifts, or other expenses can weigh on...

Synopsys raises its 2026 outlook as EDA demand accelerates, Design IP rebounds and Ansys integration opens growth opportunities for fiscal 2027.